TY - JOUR
T1 - Parenting a child with Marfan syndrome
T2 - Distress and everyday problems
AU - Warnink-Kavelaars, Jessica
AU - van Oers, Hedy A
AU - Haverman, Lotte
AU - Buizer, Annemieke I
AU - Alsem, Mattijs W
AU - Engelbert, Raoul H H
AU - Menke, Leonie A
N1 - Funding Information:
We thank the parents who participated in this study. We are grateful to SIA RAAK-PRO, part of the Dutch Organization for Scientific Research (NWO;SVB.RAAK>PRO02.007), for funding this project, which is part of a 4-year research grant of the project ?Follow You-Children with a connective tissue disorder.? We thank Ad Backx, pediatric-cardiologist; Elke Kraal-Biezen, ophthalmologist; Marieke Baars, clinical geneticist; Madeleine Tilburgs, pediatric nurse; and Alessandra Maugeri, molecular geneticist for their role in the Amsterdam Expert Center for children with Marfan syndrome and related disorders. We thank the Dutch MFS patient association and the European Reference Network (ERN), Skin, Mendelian Connective Tissue Disorders for the fruitful discussions.
Funding Information:
We thank the parents who participated in this study. We are grateful to SIA RAAK‐PRO, part of the Dutch Organization for Scientific Research (NWO;SVB.RAAK>PRO02.007), for funding this project, which is part of a 4‐year research grant of the project “Follow You‐Children with a connective tissue disorder.” We thank Ad Backx, pediatric‐cardiologist; Elke Kraal‐Biezen, ophthalmologist; Marieke Baars, clinical geneticist; Madeleine Tilburgs, pediatric nurse; and Alessandra Maugeri, molecular geneticist for their role in the Amsterdam Expert Center for children with Marfan syndrome and related disorders. We thank the Dutch MFS patient association and the European Reference Network (ERN), Skin, Mendelian Connective Tissue Disorders for the fruitful discussions.
Publisher Copyright:
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - Marfan syndrome (MFS) is a multisystemic, autosomal dominant connective tissue disorder that occurs de novo in 25%. In many families, parent and child(ren) are affected, which may increase distress in parents. To assess distress, 42 mothers (29% MFS) and 25 fathers (60% MFS) of 43 affected children, completed the validated screening-questionnaire Distress thermometer for parents of a chronically ill child, including questions on overall distress (score 0-10; ≥4 denoting "clinical distress") and everyday problems (score 0-36). Data were compared to 1,134 control-group-parents of healthy children. Mothers reported significantly less overall distress (2, 1-4 vs. 3, 1-6; p = .049; r = -.07) and total everyday problems (3, 0-6 vs. 4, 1-8; p = .03; r = -.08) compared to control-group-mothers. Mothers without MFS reported significantly less overall distress compared to mothers with MFS, both of a child with MFS (1, 0-4 vs. 3.5, 2-5; p = .039; r = -.17). No significant differences were found between the father-groups, nor between the group of healthy parents of an affected child living together with an affected partner compared to control-group-parents. No differences in percentages of clinical distress were reported between mothers and control-group-mothers (33 vs. 42%); fathers and control-group-fathers (28 vs. 32%); nor between the other groups. Distress was not associated with the children's MFS characteristics. Concluding, parents of a child with MFS did not show more clinical distress compared to parents of healthy children. However, clinical distress was reported in approximately one-third and may increase in case of acute medical complications. We advise monitoring distress in parents of a child with MFS to provide targeted support.
AB - Marfan syndrome (MFS) is a multisystemic, autosomal dominant connective tissue disorder that occurs de novo in 25%. In many families, parent and child(ren) are affected, which may increase distress in parents. To assess distress, 42 mothers (29% MFS) and 25 fathers (60% MFS) of 43 affected children, completed the validated screening-questionnaire Distress thermometer for parents of a chronically ill child, including questions on overall distress (score 0-10; ≥4 denoting "clinical distress") and everyday problems (score 0-36). Data were compared to 1,134 control-group-parents of healthy children. Mothers reported significantly less overall distress (2, 1-4 vs. 3, 1-6; p = .049; r = -.07) and total everyday problems (3, 0-6 vs. 4, 1-8; p = .03; r = -.08) compared to control-group-mothers. Mothers without MFS reported significantly less overall distress compared to mothers with MFS, both of a child with MFS (1, 0-4 vs. 3.5, 2-5; p = .039; r = -.17). No significant differences were found between the father-groups, nor between the group of healthy parents of an affected child living together with an affected partner compared to control-group-parents. No differences in percentages of clinical distress were reported between mothers and control-group-mothers (33 vs. 42%); fathers and control-group-fathers (28 vs. 32%); nor between the other groups. Distress was not associated with the children's MFS characteristics. Concluding, parents of a child with MFS did not show more clinical distress compared to parents of healthy children. However, clinical distress was reported in approximately one-third and may increase in case of acute medical complications. We advise monitoring distress in parents of a child with MFS to provide targeted support.
KW - Marfan syndrome
KW - autosomal dominant
KW - chronic illness
KW - connective tissue disorder
KW - distress
KW - parents
UR - http://www.scopus.com/inward/record.url?scp=85092190545&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.61906
DO - 10.1002/ajmg.a.61906
M3 - Article
C2 - 33034422
VL - 185
SP - 50
EP - 59
JO - American Journal of Medical Genetics Part A
JF - American Journal of Medical Genetics Part A
SN - 1552-4825
IS - 1
ER -